Skip to content

Agilon Health AGL Change in AP

Change in AP at other companies

CVS Health logo
CVS HealthCVS
-$562M-121%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
-$16.25M-17.3%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$2.96M+174%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$124.58M-10.6%
Centene logo
CenteneCNC
$2.91B+416%
National Healthcare logo
National HealthcareNHC
-$1.4M+63.7%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Agilon Health’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's change in AP?
Agilon Health (AGL) reported change in AP of -$21.4M in Q4 2025.
How has Agilon Health's change in AP changed year-over-year?
Agilon Health's change in AP decreased by 1946.5% year-over-year, from $1.16M to -$21.4M.
What is the long-term trend for Agilon Health's change in AP?
Over 4 years (2021 to 2025), Agilon Health's change in AP has grown at a 45.0% compound annual growth rate (CAGR), from $19.36M to -$85.59M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.